Actively Recruiting
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
Led by AbbVie · Updated on 2026-01-20
3000
Participants Needed
4
Research Sites
240 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the safety and effectiveness of atogepant for the preventive treatment of migraine in Korean adult patients with chronic migraine or episodic migraine under routine clinical practice. Atogepant is an approved drug for preventive treatment of migraine in adults. Approximately 3000 adult participants who are prescribed atogepant by their doctors will be enrolled in this study in Korea. Participants will receive atogepant oral tablets as prescribed by their physician. Participants will be followed for up to week 12. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
CONDITIONS
Official Title
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants with migraine suitable for treatment with atogepant according to the latest approved local label
- Participants prescribed atogepant in accordance with the approved local label
You will not qualify if you...
- Participants with any contraindication to atogepant as listed on the latest approved local label
- Participants currently participating in another clinical research except observational study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Hallym University Dongtan Sacred Heart Hospital /ID# 273581
Hwaseong, Gyeonggido, South Korea, 18450
Actively Recruiting
2
Seoul National University Hospital /ID# 271892
Seoul, Seoul Teugbyeolsi, South Korea, 03080
Actively Recruiting
3
Kangbuk Samsung Hospital /ID# 271893
Seoul, Seoul Teugbyeolsi, South Korea, 03181
Actively Recruiting
4
Yonsei University Health System Severance Hospital /ID# 272639
Seoul, Seoul Teugbyeolsi, South Korea, 03722
Actively Recruiting
Research Team
C
Celine Im
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here